| RS2527327500 |
FH
|
Health Risk |
Pathogenic |
Hereditary leiomyomatosis and renal cell cancer, Hereditary leiomyomatosis and renal cell cancer |
| RS2527327569 |
FH
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2527327584 |
FH
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary leiomyomatosis and renal cell cancer |
| RS2527327592 |
FH
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2527327612 |
FH
|
Health Risk |
Likely pathogenic |
— |
| RS2527328347 |
ADAM17
|
Health Risk |
Pathogenic |
Inflammatory skin and bowel disease, neonatal |
| RS2527332379 |
FH
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2527332427 |
FH
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2527332504 |
FH
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2527332571 |
FH
|
Health Risk |
Pathogenic |
— |
| RS2527332585 |
FH
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary leiomyomatosis and renal cell cancer, Fumarase deficiency |
| RS2527332608 |
FH
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2527332795 |
FH
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2527332800 |
FH
|
Health Risk |
Pathogenic |
— |
| RS2527332814 |
FH
|
Health Risk |
Pathogenic |
Hereditary leiomyomatosis and renal cell cancer, Hereditary leiomyomatosis and renal cell cancer |
| RS2527332897 |
FH
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2527335176 |
FH
|
Health Risk |
Likely pathogenic |
Fumarase deficiency, Fumarase deficiency |
| RS2527335211 |
FH
|
Health Risk |
Pathogenic |
— |
| RS2527335224 |
FH
|
Health Risk |
Pathogenic |
Hereditary leiomyomatosis and renal cell cancer, Hereditary leiomyomatosis and renal cell cancer |
| RS2527335251 |
FH
|
Health Risk |
Pathogenic |
— |
| RS2527335338 |
FH
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2527335439 |
ASPM
|
Health Risk |
Likely pathogenic |
Microcephaly 5, primary |
| RS2527340114 |
FH
|
Health Risk |
Likely pathogenic |
— |
| RS2527340172 |
FH
|
Health Risk |
Pathogenic |
— |
| RS2527340210 |
FH
|
Health Risk |
Pathogenic |
Hereditary leiomyomatosis and renal cell cancer, Hereditary leiomyomatosis and renal cell cancer |
| RS2527340288 |
FH
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary leiomyomatosis and renal cell cancer |
| RS2527340320 |
FH
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2527341649 |
CDC73
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2527344866 |
FH
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2527345537 |
FH
|
Health Risk |
Likely pathogenic |
Fumarase deficiency, Fumarase deficiency |
| RS2527345547 |
ASPM
|
Health Risk |
Likely pathogenic |
Microcephaly 5, primary |
| RS2527345613 |
FH
|
Health Risk |
Conflicting classifications of pathogenicity |
Fumarase deficiency, Hereditary cancer-predisposing syndrome |
| RS2527347805 |
ASPM
|
Health Risk |
Likely pathogenic |
— |
| RS2527352424 |
ASPM
|
Health Risk |
Pathogenic |
— |
| RS2527355524 |
ASPM
|
Health Risk |
Pathogenic |
— |
| RS2527358629 |
EGLN1
|
Health Risk |
Pathogenic |
Erythrocytosis, familial |
| RS2527360102 |
EGLN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Erythrocytosis, familial |
| RS2527360670 |
EGLN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Erythrocytosis, familial |
| RS2527361700 |
ADAM17
|
Health Risk |
Pathogenic |
Inflammatory skin and bowel disease, neonatal |
| RS2527363360 |
LYST
|
Health Risk |
Likely pathogenic |
Chédiak-Higashi syndrome, Chédiak-Higashi syndrome |
| RS2527363381 |
LYST
|
Health Risk |
Likely pathogenic |
Chédiak-Higashi syndrome, Chédiak-Higashi syndrome |
| RS2527363448 |
LYST
|
Health Risk |
Pathogenic |
Chédiak-Higashi syndrome, Chédiak-Higashi syndrome |
| RS2527363613 |
LYST
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Chédiak-Higashi syndrome |
| RS2527363889 |
LYST
|
Health Risk |
Pathogenic |
Chédiak-Higashi syndrome, Chédiak-Higashi syndrome |
| RS2527364187 |
ASPM
|
Health Risk |
Likely pathogenic |
Microcephaly 5, primary |
| RS2527364273 |
LYST
|
Health Risk |
Pathogenic/Likely pathogenic |
Chédiak-Higashi syndrome, Chédiak-Higashi syndrome |
| RS2527364709 |
LYST
|
Health Risk |
Pathogenic |
Chédiak-Higashi syndrome, Chédiak-Higashi syndrome |
| RS2527366225 |
ASPM
|
Health Risk |
Pathogenic |
Microcephaly 5, primary |
| RS2527366256 |
ASPM
|
Health Risk |
Pathogenic |
— |
| RS2527368289 |
ASPM
|
Health Risk |
Likely pathogenic |
— |
| RS2527377406 |
ASPM
|
Health Risk |
Pathogenic |
— |
| RS2527377771 |
ASPM
|
Health Risk |
Pathogenic |
— |
| RS2527380441 |
LYST
|
Health Risk |
Likely pathogenic |
Chédiak-Higashi syndrome, Chédiak-Higashi syndrome |
| RS2527380452 |
LYST
|
Health Risk |
Likely pathogenic |
Chédiak-Higashi syndrome, Chédiak-Higashi syndrome |
| RS2527382078 |
ASPM
|
Health Risk |
Pathogenic |
— |
| RS2527386785 |
PTPRC
|
Health Risk |
Likely pathogenic |
Immunodeficiency 104, Immunodeficiency 104 |
| RS2527387206 |
ADAM17
|
Health Risk |
Likely pathogenic |
Inflammatory skin and bowel disease, neonatal |
| RS2527395336 |
RYR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Catecholaminergic polymorphic ventricular tachycardia 1 |
| RS2527402086 |
ASPM
|
Health Risk |
Likely pathogenic |
Microcephaly 5, primary |
| RS2527402182 |
ASPM
|
Health Risk |
Pathogenic |
— |
| RS2527402190 |
ASPM
|
Health Risk |
Pathogenic |
ASPM-related disorder, ASPM-related disorder |
| RS2527402336 |
ASPM
|
Health Risk |
Pathogenic |
— |
| RS2527402674 |
ASPM
|
Health Risk |
Likely pathogenic |
Microcephaly 5, primary |
| RS2527403784 |
KIDINS220
|
Health Risk |
Pathogenic |
Spastic paraplegia, intellectual disability |
| RS2527403805 |
ASPM
|
Health Risk |
Pathogenic |
Microcephaly 5, primary |
| RS2527403897 |
ASPM
|
Health Risk |
Pathogenic |
— |
| RS2527405766 |
ASPM
|
Health Risk |
Pathogenic |
— |
| RS2527405925 |
ASPM
|
Health Risk |
Pathogenic |
— |
| RS2527406250 |
KIDINS220
|
Health Risk |
Conflicting classifications of pathogenicity |
Kabuki syndrome 1, Spastic paraplegia |
| RS2527406464 |
ASPM
|
Health Risk |
Likely pathogenic |
Microcephaly 5, primary |
| RS2527407129 |
KIDINS220
|
Health Risk |
Likely pathogenic |
Spastic paraplegia, intellectual disability |
| RS2527407498 |
ASPM
|
Health Risk |
Likely pathogenic |
Microcephaly 5, primary |
| RS2527408276 |
KDM5B
|
Health Risk |
Likely pathogenic |
— |
| RS2527408768 |
PKD1
|
Health Risk |
Pathogenic |
PKD1-related disorder, PKD1-related disorder |
| RS2527411037 |
KDM5B
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal recessive 65 |
| RS2527411857 |
KDM5B
|
Health Risk |
Likely pathogenic |
KDM5B-related disorder, KDM5B-related disorder |
| RS2527412530 |
ASPM
|
Health Risk |
Likely pathogenic |
Microcephaly 5, primary |
| RS2527417596 |
LYST
|
Health Risk |
Likely pathogenic |
Chédiak-Higashi syndrome, Chédiak-Higashi syndrome |
| RS2527417604 |
LYST
|
Health Risk |
Likely pathogenic |
Chédiak-Higashi syndrome, Chédiak-Higashi syndrome |
| RS2527417689 |
LYST
|
Health Risk |
Likely pathogenic |
Chédiak-Higashi syndrome, Chédiak-Higashi syndrome |
| RS2527417807 |
LYST
|
Health Risk |
Pathogenic |
Chédiak-Higashi syndrome, Chédiak-Higashi syndrome |
| RS2527417930 |
LYST
|
Health Risk |
Pathogenic |
Chédiak-Higashi syndrome, Chédiak-Higashi syndrome |
| RS2527421668 |
KDM5B
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal recessive 65 |
| RS2527424311 |
KIDINS220
|
Health Risk |
Likely pathogenic |
— |
| RS2527424387 |
KIDINS220
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2527424554 |
KIDINS220
|
Health Risk |
Likely pathogenic |
— |
| RS2527424853 |
HUWE1
|
Health Risk |
Likely pathogenic |
— |
| RS2527426205 |
KDM5B
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal recessive 65 |
| RS2527427721 |
KIDINS220
|
Health Risk |
Pathogenic |
— |
| RS2527429518 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2527429789 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2527429907 |
USH2A
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS2527429954 |
USH2A
|
Health Risk |
Likely pathogenic |
— |
| RS2527433418 |
USH2A
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 39, Retinitis pigmentosa 39 |
| RS2527433429 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2527433665 |
USH2A
|
Health Risk |
Likely pathogenic |
Usher syndrome type 2A, Usher syndrome type 2A |
| RS2527433682 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2527433698 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2527433742 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2527433750 |
USH2A
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 39, Retinitis pigmentosa 39 |